CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

About This Presentation
Title:

CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES MARKET ANALYSIS (2020-2027)

Description:

Read here the market research report on the “Cardiovascular Monitoring and Diagnostic Devices Market" published by CMI Team – PowerPoint PPT presentation

Number of Views:84

less

Transcript and Presenter's Notes

Title: CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES MARKET ANALYSIS (2020-2027)


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES
MARKET ANALYSIS(2020-2027)
  • Cardiovascular Monitoring and Diagnostic Devices
    Market, By Product Type (ECG Monitoring Device,
    Holter Monitoring Device, ECG Stress Testing,
    Event Monitoring Devices), By End User
    (Hospitals, Ambulatory Surgical Centers,
    Clinics), and By Region (North America, Latin
    America, Europe, Asia Pacific, Middle East
    Africa) - Size, Share, Outlook, and Opportunity
    Analysis, 2020 - 2027

3
  • Cardiac monitoring generally refers to continuous
    or intermittent monitoring of heart activity,
    generally by electrocardiography, with assessment
    of the patient's condition relative to their
    cardiac rhythm. ECG monitoring devices, Holter
    monitoring devices, ECG stress testing devices,
    and event monitoring devices are discussed in the
    report.
  • The global cardiovascular monitoring and
    diagnostic devices market is estimated to account
    for US 2,200.6 Mn in terms of value in 2020 and
    is expected to reach US 4,481.8 Mn by the end of
    2027.

4
Global Cardiovascular Monitoring and Diagnostic
Devices Market Drivers
  • Increasing prevalence of cardiovascular diseases
    is expected to propel growth of the global
    cardiovascular monitoring and diagnostic devices
    market over the forecast period. For instance,
    according to the American Heart Association's
    Heart and Stroke Statistics 2019 Update, around
    48 of all adults in the U.S. suffered from some
    type of cardiovascular disease in 2016.   

5
  • Moreover, increasing geriatric population is also
    expected to aid in growth of the market. For
    instance, according to the U.S. Census Bureau,
    the U.S. geriatric population is expected to
    reach 77 million by 2034.     
  • ECG Monitoring Device held dominant position in
    the global cardiovascular monitoring and
    diagnostic devices market in 2019, accounting
    for 51.6 share in terms of value, followed
    by Holter Monitoring Device and ECG Stress
    Testing, respectively.

6
Figure 1. Global Cardiovascular Monitoring and
Diagnostic Devices Market Share (), by Value, by
Product Type, 2019
7
Global Cardiovascular Monitoring and Diagnostic
Devices Market Restraints
  • Lengthy medical device approval period is
    expected to hinder growth of the global
    cardiovascular monitoring and diagnostic devices
    market. The U.S. FDA has implemented rules for
    in-vitro testing of ECG Devices, which includes
    environmental testing, software testing,
    electrical safety, and electromagnetic
    compatibility of the devices. Moreover, the time
    needed to process and approve 510(K) increased
    from 90 days to 140 days due to the complexity
    and volume of medical devices marketing
    submissions.

8
(No Transcript)
9
  • Moreover, handheld ECG devices offer limited
    information compared to conventional lead ECGs,
    which is also expected to limit growth of the
    market.
  • The global cardiovascular monitoring and
    diagnostic devices market was valued at US
    1,987.9 Mn in 2019 and is forecast to reach a
    value of US 4,481.8 Mn by 2027 at a CAGR of
    10.7 between 2020 and 2027.

10
  • Figure 2. Global Cardiovascular Monitoring and
    Diagnostic Devices Market Value (US Mn), and
    Y-o-Y Growth (), 2019-2027

11
Market Trends/Key Takeaways
  • RD in ambulatory ECGs is boosting growth of the
    market. For instance, in February 2020,
    researchers at University of Electronic Science
    and Technology of China developed an adaptive
    cancellation algorithm based on multi-inertial
    sensors to suppress motion artifacts in
    ambulatory ECGs.

12
  • Increasing investment in development of new
    devices is also boosting growth of the market.
    For instance, in December 2019,         
    Biotricity Inc., a medical diagnostic and
    consumer healthcare technology company, raised
    US 6 million for FDA Filing for its patch
    solution within the first 6 months of 2020, which
    will be a novel product in the field of Holter
    monitoring.
  • The market is witnessing development of web-based
    remote cardiac monitoring solutions. For
    instance, in November 2019, Bittium Corporation,
    a Finland-based cardiology and neurology device
    company, presented Bittium HolterPlus, a
    web-based remote cardiac monitoring solution,
    consisting of a Bittium Faros ECG device and
    Bittium HolterPlus mobile application, at Medica
    2019, a leading international trade fair for the
    medical sector that was held in Germany.

13
Global Cardiovascular Monitoring and Diagnostic
Devices Market Competitive Landscape
  • Major players operating in the global
    cardiovascular monitoring and diagnostic devices
    market include, GE Healthcare, Philips
    Healthcare, Nihon Kohden, Schiller AG, Opto
    Circuits (India) Limited, Welch Allyn, Fukuda
    Denshi Co., Ltd., Lidco Group plc, Biotricity
    Inc., Bittium Corporation, and VivaQuant.

14
Global Cardiovascular Monitoring and Diagnostic
Devices Market Key Developments
  • Major players in the market are focused on
    approval and launch of new devices to expand
    their product portfolio. For instance, in January
    2020, Withings launched ScanWatch, which has a
    built-in ECG and a SpO2 sensor to measure oxygen
    saturation levels.
  • Similarly, in April 2019, VivaQuant, a digital
    health company, received the U.S. FDA clearance
    for its RX-1 wearable device that can operate as
    a Holter monitor.

15
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//www.coherentmarketinsights.com/
    market-insight/cardiovascular-monitoring-and-diagn
    ostic-devices-market-4021

16
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

17
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

18
  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
Write a Comment
User Comments (0)
About PowerShow.com